Business Description
Lumos Diagnostics Holdings Ltd
NAICS : 339112
SIC : 3845
ISIN : AU0000157091
Share Class Description:
ASX:LDX: Ordinary SharesDescription
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.24 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.36 | |||||
Beneish M-Score | -1.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -35 | |||||
3-Year EBITDA Growth Rate | 70.1 | |||||
3-Year EPS without NRI Growth Rate | 56.2 | |||||
3-Year FCF Growth Rate | 52.5 | |||||
3-Year Book Growth Rate | -51.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.64 | |||||
9-Day RSI | 43.17 | |||||
14-Day RSI | 41.73 | |||||
3-1 Month Momentum % | -53.19 | |||||
6-1 Month Momentum % | -61.4 | |||||
12-1 Month Momentum % | 323.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.73 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 80.48 | |||||
Days Sales Outstanding | 54.2 | |||||
Days Payable | 198.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.6 | |||||
Shareholder Yield % | 1.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.16 | |||||
Operating Margin % | -89.76 | |||||
Net Margin % | -75.76 | |||||
EBITDA Margin % | -51.23 | |||||
FCF Margin % | -20.58 | |||||
OCF Margin % | -18.77 | |||||
ROE % | -128.73 | |||||
ROA % | -39.99 | |||||
ROIC % | -50.97 | |||||
3-Year ROIIC % | -119.44 | |||||
ROC (Joel Greenblatt) % | -135.51 | |||||
ROCE % | -65.49 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.2 | |||||
PB Ratio | 10.5 | |||||
EV-to-EBIT | -7.86 | |||||
EV-to-EBITDA | -10.95 | |||||
EV-to-Revenue | 5.62 | |||||
EV-to-Forward-Revenue | 1.68 | |||||
EV-to-FCF | -29.74 | |||||
Price-to-GF-Value | 5.25 | |||||
Earnings Yield (Greenblatt) % | -12.72 | |||||
FCF Yield % | -3.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lumos Diagnostics Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 18.571 | ||
| EPS (TTM) (A$) | -0.018 | ||
| Beta | 5.0691 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 4.55 | ||
| Volatility % | 195.69 | ||
| 14-Day RSI | 41.73 | ||
| 14-Day ATR (A$) | 0.010365 | ||
| 20-Day SMA (A$) | 0.10745 | ||
| 12-1 Month Momentum % | 323.08 | ||
| 52-Week Range (A$) | 0.027 - 0.33 | ||
| Shares Outstanding (Mil) | 944.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lumos Diagnostics Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lumos Diagnostics Holdings Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2025 | 2025-04-22 | 0.03 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-01-30 | 0.04 (-6.98%) | ||
| General meeting for 2024 | 2024-11-01 09:00 | 0.04 (+5.88%) | ||
| First quarter earnings results for 2025 | 2024-10-30 | 0.04 (-11.90%) | ||
| Annual report for 2024 | 2024-08-29 | 0.04 (-2.44%) | ||
| Fourth quarter earnings results for 2024 | 2024-07-19 | 0.04 (+4.76%) |
Show
Entries
Lumos Diagnostics Holdings Ltd Frequently Asked Questions
What is Lumos Diagnostics Holdings Ltd(ASX:LDX)'s stock price today?
The current price of ASX:LDX is A$0.11. The 52 week high of ASX:LDX is A$0.33 and 52 week low is A$0.03.
When is next earnings date of Lumos Diagnostics Holdings Ltd(ASX:LDX)?
The next earnings date of Lumos Diagnostics Holdings Ltd(ASX:LDX) is .
Does Lumos Diagnostics Holdings Ltd(ASX:LDX) pay dividends? If so, how much?
Lumos Diagnostics Holdings Ltd(ASX:LDX) does not pay dividend.
Press Release
Articles on Lumos Diagnostics Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers